Jochen Hess
约亨·赫斯
PhD
Professor of Experimental Head and Neck Oncology; Head, Molecular Mechanisms of Head and Neck Tumors Section实验头颈肿瘤学教授;头颈肿瘤分子机制研究组负责人
👥Biography 个人简介
Jochen Hess, PhD is Professor of Experimental Head and Neck Oncology at Heidelberg University Hospital and leads the Molecular Mechanisms of Head and Neck Tumors section at the German Cancer Research Center (DKFZ). He is an international authority on the molecular virology of HPV-associated HNSCC, the immunobiology of the HPV+ tumor microenvironment, and translational development of therapeutic HPV vaccines. His laboratory has defined key molecular signatures distinguishing HPV-positive from HPV-negative HNSCC and has identified viral oncoproteins E6 and E7 as optimal targets for therapeutic vaccination and adoptive T-cell therapy in oropharyngeal cancer. He has also contributed to large-scale genomic analyses of HNSCC within the TCGA consortium and DKFZ-led translational programs, and serves as a scientific coordinator for European Head and Neck Society (EHNS) research initiatives. Dr. Hess has published over 200 peer-reviewed studies and holds patents on HPV-targeting immunotherapy strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Molecular Classification of HPV-Positive vs HPV-Negative HNSCC
Generated and published comprehensive molecular profiling of HPV-positive and HPV-negative HNSCC revealing distinct transcriptional programs, immune infiltration patterns, and driver mutation landscapes, informing the biological rationale for differential treatment strategies.
Therapeutic HPV Vaccines for Oropharyngeal Cancer
Led preclinical and translational development of therapeutic vaccines targeting HPV-16 E6 and E7 oncoproteins in HPV-positive HNSCC, including mRNA-based and peptide-based vaccine platforms, with early-phase clinical studies showing T-cell responses in oropharyngeal cancer patients.
Tumor Microenvironment Immunobiology in HPV+ HNSCC
Characterized the immunosuppressive mechanisms operative within the HPV-positive oropharyngeal tumor microenvironment, including regulatory T-cell enrichment, IDO pathway activation, and PD-L1/PD-L2 expression driven by viral E6/E7, guiding combination immunotherapy design.
DKFZ-HNSCC Translational Genomics Program
Coordinated German-Austrian translational genomics initiative generating multi-omics datasets (WGS, RNA-seq, methylome) for HNSCC, identifying recurrent alterations in FAT1, NOTCH1, and epigenetic regulators and linking molecular subtypes with clinical outcome.
Representative Works 代表性著作
Immune evasion in HPV-positive oropharyngeal squamous cell carcinoma: role of viral E6/E7 oncoproteins in PD-L1 regulation
Cancer Research (2020)
Study demonstrating that HPV-16 E6 and E7 oncoproteins directly regulate PD-L1 expression through JAK/STAT and IRF3 pathways in OPSCC, providing mechanistic support for anti-PD-1/PD-L1 therapy in HPV+ disease.
Genomic landscape of head and neck squamous cell carcinoma: a comprehensive multi-omics analysis
Nature Genetics (2018)
Integrative genomic analysis of HNSCC identifying distinct molecular subgroups driven by HPV, FAT1 alterations, and epigenetic dysregulation with differential prognostic significance.
HPV-16 E7 peptide vaccine combined with immune checkpoint blockade in recurrent HPV-positive head and neck cancer
Journal for ImmunoTherapy of Cancer (2022)
Early-phase clinical and translational study demonstrating T-cell immunogenicity and preliminary clinical activity of an E7 peptide vaccine combined with anti-PD-1 in HPV-positive R/M HNSCC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bing Ren
University of California San Diego, Ludwig Cancer Research
Cigall Kadoch
Dana-Farber Cancer Institute / Broad Institute of MIT and Harvard
Luciano Di Croce
Centre for Genomic Regulation (CRG), Barcelona
Alexander Meissner
Max Planck Institute for Molecular Genetics, Berlin
关注 约亨·赫斯 的研究动态
Follow Jochen Hess's research updates
留下邮箱,当我们发布与 Jochen Hess(Heidelberg University Hospital / German Cancer Research Center (DKFZ))相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment